NEXTURNBIOSCIENCE Co., Ltd. (KOSDAQ: 089140)
South Korea
· Delayed Price · Currency is KRW
2,840.00
-40.00 (-1.39%)
Jan 22, 2025, 3:00 PM KST
NEXTURNBIOSCIENCE Revenue
NEXTURNBIOSCIENCE had revenue of 9.89B KRW in the quarter ending September 30, 2024, a decrease of -3.53%. This brings the company's revenue in the last twelve months to 35.86B, down -7.32% year-over-year. In the year 2023, NEXTURNBIOSCIENCE had annual revenue of 41.26B with 75.84% growth.
Revenue (ttm)
35.86B
Revenue Growth
-7.32%
P/S Ratio
0.82
Revenue / Employee
629.08M
Employees
57
Market Cap
34.55B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 41.26B | 17.79B | 75.84% |
Dec 31, 2022 | 23.46B | 6.49B | 38.24% |
Dec 31, 2021 | 16.97B | 7.29B | 75.24% |
Dec 31, 2020 | 9.69B | -15.43B | -61.43% |
Dec 31, 2010 | 25.11B | 13.24B | 111.45% |
Dec 31, 2009 | Pro | Pro | Pro |
Dec 31, 2008 | Pro | Pro | Pro |
Dec 31, 2007 | Pro | Pro | Pro |
Dec 31, 2006 | Pro | Pro | Pro |
Dec 31, 2005 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Electronics | 292.86T |
SK hynix | 57.73T |
LG Energy Solution | 27.17T |
Samsung Biologics Co.,Ltd. | 4,364.39B |
Hyundai Motor Company | 170.28T |
Kia Corporation | 104.63T |
Celltrion | 2,876.25B |
KB Financial Group | 14.11T |